Inflammatoire darmziekten, waaronder colitis ulcerosa en de ziekte van Crohn, worden gekarakteriseerd door chronische ontstekingen in het darmkanaal. Een groep patiënten reageert onvoldoende op reguliere therapie met aminosalicylaten en corticosteroïden. Fytotherapeutica, als monotherapie of in combinatie met medicijnen, kunnen effectief en veilig worden ingezet om de ziekte onder controle te krijgen en opflakkeringen te voorkomen.
Beste bezoeker, u heeft geen toegang.
Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.
U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!
Auteur
Verschenen in
Referenties
Vindigni SM, Zisman TL, Suskind DL, Damman CJ. The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. Therap Adv Gastroenterol. 2016 Jul 22;9(4):606–25.
Holleran G, Scaldaferri F, Gasbarrini A, Currò D. Herbal medicinal products for inflammatory bowel disease: A focus on those assessed in double‐blind randomised controlled trials. Phyther Res. 2020 Jan 7;34(1):77–93.
Guo B-J, Bian Z-X, Qiu H-C, Wang Y-T, Wang Y. Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease. Ann N Y Acad Sci. 2017 Aug 1;1401(1):37–48.
Larussa T, Imeneo M, Luzza F. Potential role of nutraceutical compounds in inflammatory bowel disease. Vol. 23, World Journal of Gastroenterology. Baishideng Publishing Group Co., Limited; 2017. p. 2483–92.
Kamalian A, Asl MS, Dolatshahi M, Afshari K, Shamshiri S, Roudsari NM, et al. Interventions of natural and synthetic agents in inflammatory bowel disease, modulation of nitric oxide pathways. Vol. 26, World Journal of Gastroenterology. Baishideng Publishing Group Co., Limited; 2020. p. 3365–400.
Goulart R de A, Barbalho SM, Lima VM, Souza GA de, Matias JN, Araújo AC, et al. Effects of the Use of Curcumin on Ulcerative Colitis and Crohn’s Disease: A Systematic Review. J Med Food. 2020 Nov 5;jmf.2020.0129.
Langhorst J, Koch AK, Voiss P, Dobos GJ, Rueffer A. Distinct patterns of short-chain fatty acids during flare in patients with ulcerative colitis under treatment with mesalamine or a herbal combination of myrrh, chamomile flowers, and coffee charcoal. Eur J Gastroenterol Hepatol. 2020 Feb 1;32(2):175–80.
Ganji-Arjenaki M, Rafieian-Kopaei M. Phytotherapies in inflammatory bowel disease. Vol. 24, Journal of Research in Medical Sciences. Wolters Kluwer Medknow Publications; 2019.
ESCOP monograph - Aloe barbadensis (Barbados aloes) [Internet]. [cited 2020 Nov 13]. Available from: https://escop.com/aloe-barbadensis-barbados-aloes-online-consultation/
Triantafyllidi A, Xanthos T, Papalois A, Triantafillidis JK. Herbal and plant therapy in patients with inflammatory bowel disease. Vol. 28, Annals of Gastroenterology. Hellenic Society of Gastroenterology; 2015. p. 210–20.
ESCOP monograph - Tormentillae rhizoma (Tormentil) [Internet]. [cited 2020 Nov 9]. Available from: https://escop.com/tormentillae-rhizoma-tormentil-online-consultation/
Holtmeier W, Zeuzem S, Prei J, Kruis W, Böhm S, Maaser C, et al. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohnʼs disease. Inflamm Bowel Dis. 2011 Feb 1;17(2):573–82.
Gerhardt H, Seifert F, Buvari P, Vogelsang H, Repges R. Therapie des aktiven Morbus Crohn mit dem Boswellia-serrata-Extrakt H 15. Z Gastroenterol. 2001 Jan 1;39(1):11–7.
Papada E, Forbes A, Amerikanou C, Torović L, Kalogeropoulos N, Tzavara C, et al. Antioxidative Efficacy of a Pistacia Lentiscus Supplement and Its Effect on the Plasma Amino Acid Profile in Inflammatory Bowel Disease: A Randomised, Double-Blind, Placebo-Controlled Trial. Nutrients. 2018 Nov 16;10(11):1779.
Papada E, Amerikanou C, Torović L, Kalogeropoulos N, Tzavara C, Forbes A, et al. Plasma free amino acid profile in quiescent Inflammatory Bowel Disease patients orally administered with Mastiha (Pistacia lentiscus); a randomised clinical trial. Phytomedicine. 2019 Mar;56:40–7.
Kienzl M, Storr M, Schicho R. Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases. Clin Transl Gastroenterol. 2020 Jan 1;11(1):e00120.
Kafil TS, Nguyen TM, MacDonald JK, Chande N. Cannabis for the treatment of ulcerative colitis. Cochrane Database Syst Rev. 2018 Nov 8;
Kafil TS, Nguyen TM, Macdonald JK, Chande N. Cannabis for the treatment of Crohn’s disease. Vol. 2018, Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd; 2018.
Coelho MR, Romi MD, Ferreira DMTP, Zaltman C, Soares-Mota M. The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials. Nutrients. 2020 Jul 31;12(8):2296.
Garg SK, Ahuja V, Sankar MJ, Kumar A, Moss AC. Curcumin for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2012 Oct 17;
Suskind DL, Wahbeh G, Burpee T, Cohen M, Christie D, Weber W. Tolerability of curcumin in pediatric inflammatory bowel disease: A forced-dose titration study. J Pediatr Gastroenterol Nutr. 2013 Mar;56(3):277–9.
Rahman H, Kim M, Leung G, Green JA, Katz S. Drug-Herb Interactions in the Elderly Patient with IBD: a Growing Concern. Curr Treat Options Gastroenterol. 2017 Dec 16;15(4):618–36.
